Crescent Capital BDC, Inc.
No enriched coverage for $CCAP in the last 7 days.
Analysts downgraded several stocks: Evercore ISI cut Chewy (CHWY) to In-Line with $25 target; Baird and B of A downgraded Cooper Companies (COO) to Neutral with targets $61 and $65; BMO downgraded Anglogold Ashanti (AU) to Market Perform; B of A cut Crescent Capital (CCAP) to Neutral with $10.25 target.
FIDELITY & GUARANTY LIFE INSURANCE CO sold 265,490 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.28 ($10.23–$10.33, $2.73M total) across 2 trades over 2026-09-08 to 2026-09-09 under a Rule 10b5-1 trading plan.
FIDELITY & GUARANTY LIFE INSURANCE CO sold 56,285 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.46 ($10.44–$10.50, $0.59M total) across 2 trades over 2026-09-01 to 2026-09-02 under a Rule 10b5-1 trading plan.
Recent CCAP coverage spans insider activity, financial news and earnings.
In the last 30 days, CCAP insiders filed 14 SEC Form 4 transactions — 2 purchases ($49K) and 12 sales ($5.5M). The most active reporter was FIDELITY & GUARANTY LIFE INSURANCE CO with 12 filings. 86% of those filings were made under pre-arranged Rule 10b5-1 plans.
Downgrade could trigger a short-term dip.
The insider sale reduces Fidelity's stake but likely has minimal price impact given the modest size relative to float.
The insider sale represents a modest reduction of a 10% owner's position, potentially signaling neutral to slightly negative sentiment.
Insider sale by a 10% owner may signal reduced confidence, potentially pressuring the stock short‑term.
Insider sale may signal lack of confidence, but size is modest relative to holdings.
AlphAI scores every news story that mentions CCAP with an AI model for sentiment and relevance, and aggregates insider trades from Crescent Capital BDC, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Analysts downgraded several stocks: Evercore ISI cut Chewy (CHWY) to In-Line with $25 target; Baird and B of A downgraded Cooper Companies (COO) to Neutral with targets $61 and $65; BMO downgraded Anglogold Ashanti (AU) to Market Perform; B of A cut Crescent Capital (CCAP) to Neutral with $10.25 target.
2 min readFIDELITY & GUARANTY LIFE INSURANCE CO sold 265,490 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.28 ($10.23–$10.33, $2.73M total) across 2 trades over 2026-09-08 to 2026-09-09 under a Rule 10b5-1 trading plan.
1 min readFIDELITY & GUARANTY LIFE INSURANCE CO sold 56,285 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.46 ($10.44–$10.50, $0.59M total) across 2 trades over 2026-09-01 to 2026-09-02 under a Rule 10b5-1 trading plan.
1 min readFIDELITY & GUARANTY LIFE INSURANCE CO sold 55,000 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.62 ($10.60–$10.62, $0.58M total) across 2 trades over 2026-08-28 to 2026-08-31 under a Rule 10b5-1 trading plan.
1 min readFIDELITY & GUARANTY LIFE INSURANCE CO sold 59,286 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.60 ($10.60–$10.60, $0.63M total) across 2 trades over 2026-08-26 to 2026-08-27 under a Rule 10b5-1 trading plan.
1 min readFidelity & Guaranty Life Insurance Co, a 10% owner of Crescent Capital BDC (CCAP), sold 73,457 shares of common stock in two transactions on 2026-08-24 and 2026-08-25. The sales, executed under a Rule 10b5-1 trading plan, were at average prices of $10.72–$10.80 per share, totaling approximately $788,000.
1 min readFIDELITY & GUARANTY LIFE INSURANCE CO sold 73,457 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.73 ($10.72–$10.74, $0.79M total) across 2 trades over 2026-08-24 to 2026-08-25 under a Rule 10b5-1 trading plan.
1 min readChung Henry (President) purchased 2,500 shares of Crescent Capital BDC, Inc. (CCAP) at $10.89 on 2026-08-19.
1 min readLombard Gerhard (Chief Financial Officer) purchased 2,000 shares of Crescent Capital BDC, Inc. (CCAP) at $10.91 on 2026-08-19.
1 min readCrescent Capital BDC, Inc. reported Q2 2026 earnings call updates. Management said NAV fell to $17.82, driven by unrealized losses in non-accrual investments, and it implemented a new fee and dividend framework effective April 1. It expects to reduce leverage to target range in 2H, plans two $0.03 special dividends, and extended unsecured maturities after repaying $162 million.
6 min read
